It is quite possible that MS, DP and Co have been cagey until they had the trial results firmly in hand. After all, the results announced last week effectively put a price on the project, as opposed to just a theoretical range.
Surely the report that was compiled on the malaria treatment market would give the company sufficient information to indicate what the project is worth.
They then give some parameters to AFG regarding type of sale structure and roundabout price levels and its up to AFG to bring big pharma to Eastlands door.
It is quite possible that MS, DP and Co have been cagey until...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $2.500M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $23.14K | 1.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 196972 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 215294 | 2 |
View Market Depth
| Last trade - 10.30am 22/08/2024 (20 minute delay) ? |
| EMS (ASX) Chart |